There is little knowledge about how oral and respiratory health is interrelated even though the mucosa of the oral cavity and airways constitutes a continuum and the exposures to these are partly similar.
To investigate whether gum bleeding is related to asthma, respiratory symptoms and self-reported COPD.
A postal questionnaire including questions about respiratory and oral health was sent to general population samples in seven Northern European centres. In 13,409 responders, gum bleeding when brushing teeth was reported always/often by 4% and sometimes by 20%. Logistic regressions accounted for age, smoking, educational level, centre and gender. Effects of BMI, cardio-metabolic diseases, early life factors, gastro-oesophageal reflux, dental hygiene, nasal congestion, and asthma medication were addressed.
Gum bleeding always/often was significantly associated with ≥3 asthma symptoms (OR 2.58, 95% CI 2.10–3.18), asthma (1.62 [1.23–2.14]) and self-reported COPD (2.02 [1.28–3.18]). There was a dose-response relationship between respiratory outcomes and gum bleeding frequency (≥3 symptoms: gum bleeding sometimes 1.42 [1.25–1.60], often/always 2.58 [2.10–3.18]), and there was no heterogeneity between centres (pheterogeneity = 0.49). None of the investigated risk factors explained the associations. The observed associations were significantly stronger among current smokers (pinteraction = 0.004).
A consistent link between gum bleeding and obstructive airways disease was observed, not explained by common risk factors or metabolic factors. We speculate that oral pathogens might have unfavourable impact on the airways, and that the direct continuity of the mucosa of the oral cavity and the airways reflects a pathway that might provide novel opportunities for interventions.
Citation: Gómez Real F, Pérez Barrionuevo L, Franklin K, Lindberg E, Bertelsen RJ, Benediktsdóttir B, et al. (2016) The Association of Gum Bleeding with Respiratory Health in a Population Based Study from Northern Europe. PLoS ONE 11(1): e0147518. https://doi.org/10.1371/journal.pone.0147518
Editor: Andres R. Floto, Cambridge University, UNITED KINGDOM
Received: May 14, 2015; Accepted: January 5, 2016; Published: January 25, 2016
Copyright: © 2016 Gómez Real et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Due to Norwegian ethical and legal restrictions, all the data underlying the findings in our study cannot be made publicly available. Requests for data access can be directed to Haukeland University Hospital, 5021 Bergen, Norway, Att. Med. Director Alf H. Andreassen; e-mail: (firstname.lastname@example.org); phone: +47 55 97 50 00. Org. nr: 983 974 724.
Funding: The RHINE III was supported financially by the Norwegian Research Council (Grant No. 214123), the Bergen Medical Research Foundation, the Western Norwegian Regional Health Authorities (Grant No. 911 892 and 911 631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Faculty of Health of Aarhus University, (Project No. 240008), The Wood Dust Foundation (Project No. 444508795), the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vårdal Foundation for Health Care Science and Allergy Research, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Swedish Asthma and Allergy Association, the Icelandic Research Council, Landspitali University Hospital Research Fund, and the Estonian Science Foundation (Grant No. 4350). None of the study sponsors/funders had any role on study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had full responsibility for the decision to submit for publication.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: BMI, body mass index; CI, confidence interval; COPD, Chronic obstructive lung disease; CPI, Community Periodontal Index; ECRHS, European Respiratory Health Survey; GERD, gastroesophageal reflux disease; IgE, immunoglobulin E; OR, odds ratio; RHINE, Respiratory Health in Northern Europe; ECRHS, European Community Respiratory Health Survey
The relationship between oral and respiratory health is not well understood, although the oral cavity and the lower airways are a continuum and exposures are similar, and understanding the relationship might provide novel opportunities for interventions. Periodontitis is a very prevalent chronic inflammatory disease  affecting almost 40% of the adult population . The microbial flora of the gingivae is altered and gum bleeding is a key symptom [3, 4]. Periodontitis affects systemic health  and is associated with chronic diseases such as diabetes, Alzheimer’s disease [7, 8], atherosclerotic vascular diseases , rheumatoid arthritis , and COPD [11–15]. Gum bleeding, in particular, has been related to poor general health . Aggressive oral pathogens common in periodontitis have systemic effects and have been identified in atheromatous plaques , amniotic fluid  and placenta [19–21]. Improvement in periodontitis is related to a decrease in systemic inflammation  expressed as levels of CRP [23, 24].
Periodontitis has been associated with COPD [11–15] and periodontal treatment was found to result in improved lung function and exacerbation frequency, in a randomized controlled trial of patients with COPD and chronic periodontitis. . It is to our knowledge not known if oral health has a similar effect on asthma, as it seems to have on COPD. There are, however, data suggesting that asthma inhalers and open mouth breathing may lead to decreased saliva production, changes in pH and increased risk of plaques and caries [26–31].
In the present analysis, we investigated the associations between gum bleeding and asthma symptoms, asthma and self-reported COPD. Further, we explored potential explanations for such associations, addressing the role of smoking, asthma medication, metabolic pathways, developmental pathways, and local factors such as dental hygiene and gastro-oesophageal reflux (GERD).
Respiratory Health in Northern Europe (RHINE) III is the second follow-up of a population-based cohort from seven Northern European centres (Bergen in Norway; Umeå, Gothenburg and Uppsala in Sweden; Aarhus in Denmark; Reykjavik in Iceland and Tartu in Estonia) (www.rhine.nu). The cohort was initially recruited as part of the European Community Respiratory Health Survey (ECRHS) I stage I (www.ecrhs.org). Random population samples of men and women born 1945–73 completed postal questionnaires in 1991–93, 1999–2001 and 2010–12. Sixty-two percent of the original sample responded to RHINE III . The present report presents data from 13,409 persons.
Written consent was obtained from all the participants at each stage of the study. The Regional Committees for Medical and Health Research Ethics West in Norway, the National Bioethics Committee in Iceland, the Research Ethics Committee of the University of Tartu in Estonia, The Regional Ethical Review Board in Uppsala, Sweden and the Scientific Committees for Central Jutland in Denmark approved each stage of the study.
Respiratory symptoms, asthma and self-reported COPD
The standard ECRHS questions were used to assess respiratory symptoms and diseases (for wording see www.echrs.org). Wheezing and other respiratory symptoms were reported as 12 months prevalence. Current asthma was defined as having had asthma attacks during the last 12 months and/ or currently taking asthma medication. Self-reported COPD was defined by the question “Has a doctor ever told you that you have chronic obstructive pulmonary disease (COPD)?” Chronic bronchitis was defined as bringing up phlegm almost every day for at least three months in two consecutive years. “Three or more asthma symptoms” was defined as having answered yes to three or more of the following symptoms in the last 12 months: Wheezing or whistling from the chest; breathless when wheezing; wheezing or whistling when not having a cold; waking with feeling of tightness in chest; having been woken by attack of shortness of breath; having been woken by attack of cough; attack of asthma; currently taking any asthma medicine .
The study participants were asked about frequency of gum bleeding: “Do your gums bleed when you brush your teeth?”. The response alternatives (with response frequencies) were as follows: always (0.9%), often (3.2%), sometimes (20%), rarely (46%), never (30%).
To support the self-reported assessment of gum bleeding upon tooth brushing, we used measurements of the Community Periodontal Index (CPI)  in a sub-sample of 261 persons from Bergen. This sample was investigated as part of the ECRHS III study, performed in Bergen approximately 1 year after the RHINE III questionnaire survey. The CPI index is measured using a standardized protocol for investigation of gum bleeding on probing gingival margins, calculus and pockets. The index is coded from 0 to 4, where 0 denotes none of these periodontal conditions, and 4 denotes the highest score of pathology (pathological pocket of 6 mm or more with or without bleeding and calculus).
Smoking history was assessed by the questions “Are you a smoker?” and “Are you an ex-smoker?”; defining never smokers, current smokers and ex-smokers. The study subject’s and parent’s educational level (primary school, secondary/technical education, and college/university) were used as proxy variables for socioeconomic status. Body mass index (BMI) was calculated from self-reported weight and height, as weight in kilos per squared height in meters. Frequency of tooth brushing was assessed by the question “How often do you usually brush your teeth?” (Alternatives: Twice daily or more [83%], once daily [15%], less than daily [1.9%]). Poor dental hygiene was defined as brushing teeth less than twice daily. Gastro-oesophageal reflux (GERD) was defined as having heartburn or belching 3–5 night/week or more. Nasal congestion was defines as having a blocked nose >12 weeks during the last 12 months. Cardio-metabolic diseases (hypertension, heart disease, stroke, diabetes, obstructive sleep apnea) were assessed by simple questions of doctor’s diagnosed disease. The following early life variables were assessed: mothers age when giving birth to the participants, parental smoking, severe respiratory infections in childhood and intake of fruit during childhood. The wording of the questions is provided at www.rhine.nu.
Descriptive analyses of the study population by centre and by frequency of gum bleeding were performed. Multiple logistic regressions were used to analyse associations between gum bleeding and respiratory health. Gum bleeding never or rarely was defined as reference category; for interaction and supplementary analyses gum bleeding “sometimes” and “often or always” were collapsed into one category to define gum bleeding; for other analyses “gum bleeding sometimes” and “gum bleeding often or always” was used as separate categories to define increasing levels of gum bleeding. Associations are reported as odd ratios (OR) with 95% confidence intervals (CI).
All analyses were adjusted for sex, age, educational level, smoking habits, and study centre. Analyses were performed with additional adjustments for the following groups of variables: 1) cardio-metabolic factors, 2) factors known to influence oral health (tooth brushing frequency, gastro-oesophageal reflux, nasal congestion), and 3) early life developmental factors. Asthma medication might have a direct effect on the oral mucosa in addition to reflecting asthma disease; analyses with adjustment for asthma medication as well as analyses stratified for asthma medication were therefore presented.
Analysis of interactions between gum bleeding and gender, smoking status, low social class, BMI and asthma medication in effects on asthma symptoms were performed by including the interaction terms in logistic regression models with adjustment for basic characteristics. Potential heterogeneity between centres was analysed using meta-analysis according to derSimonian and Laird. STATA (StataCorp, College Station, TX, USA), version IC 13.1, was used in all the statistical analyses.
The study population included 53% women aged 34–66 years (mean age 52 years). Gum bleeding rarely or never was reported by 76%, and 83% reported brushing their teeth twice daily. The prevalence of gum bleeding varied considerably between centres, with frequent gum bleeding being reported by 10.3% in Estonia and 2.5% in Umeå. The prevalence of ≥3 asthma symptoms varied between centres from 10% (Arhus) to 19% (Tartu). (Table 1).
Gum bleeding was more common in persons with lower educational level. Gum bleeding increased with increasing BMI and was higher in all groups with cardio-metabolic diseases. Gum bleeding was particularly common among persons who brushed their teeth rarely, and in persons with GERD. Childhood respiratory infections and rarely eating fruits in childhood were associated with more gum bleeding in adulthood (Table 2).
The prevalence of all the respiratory outcomes increased with increasing frequency of gum bleeding. In adjusted analyses, the risk of respiratory symptoms, asthma and self-reported COPD was significantly increased, both among those with gum bleeding sometimes, and among those with gum bleeding often or always, and there was a dose-response relationship in the association for all outcomes. The risk of wheeze with shortness of breath when not having a cold (strongly suggestive of asthma) was almost tripled in those with frequent gum bleeding (Table 3).
With adjustment for different groups of covariates, the associations between gum bleeding and ≥3 asthma symptoms remained strong and statistically significant (Table 4). The association was slightly attenuated by adjustment for cardio-metabolic factors and by adjustment early life developmental factors, while adjustment for dental hygiene, GERD and nasal congestion attenuated the association somewhat more. None of the analysed covariates explained the association of gum bleeding with asthma symptoms (Table 4).
The association of gum bleeding (in two categories) with ≥3 asthma symptoms was significant in all investigated strata with the exception of persons using asthma medication (Table 5). The association was significantly stronger among current smokers as compared with never-smokers (pinteraction = 0.004), among those with lower socioeconomic status (pinteraction = 0.030), and among those not using asthma medication (Table 5).
The association of gum bleeding with ≥3 asthma symptoms appeared to be consistent in the different study centres (Fig 1); meta-analysis of this association by centre showed p heterogeneity = 0.491.
Pheterogeneity = 0.491. Boxes shows odds ratios and horizontal lines show 95% confidence intervals for each study centre, box size is proportional to number of study subjects, diamond shows combined estimate for all centres with 95% confidence interval.
Reported increasing frequency of gum bleeding upon tooth brushing was strongly associated with higher degree of periodontal pathology (linear regression, p = 0.003, not altered by adjustment for basic characteristics). CPI index 0 (no periodontal pathology in none of the measured sites in 10 teeth) was present in 71% of those reporting gum bleeding never, 59% of those reporting gum bleeding rarely, and 47% of those reporting gum bleeding sometimes. (Only 11 persons reported gum bleeding always (2) or often (9) in this subsample.)
This analysis of a large population based study found that gum bleeding was significantly associated with asthma symptoms, asthma and self-reported COPD. The associations were consistent across study centres in Northern Europe and present in sub-groups according to gender, smoking habits, social class and body mass index. A clinical validation study in a subsample showed high correlation of self-reported gum bleeding with gum bleeding on probing gingival margins. Adjustment for asthma medication, BMI, cardio-metabolic factors, developmental factors (reflected in early life characteristics) and factors acting locally did not change the association between gum bleeding and asthma symptoms. The association was significantly stronger among current smokers and among persons of lower socioeconomic status, and weaker among persons taking asthma medication.
These findings about asthma are novel, while the observed association of gum bleeding with self-reported COPD is in agreement with previous studies [11, 12]. Effects of asthma inhalers on oral health are described in the literature . However, the present analyses show that asthma symptoms were even more strongly associated with gum bleeding in asthmatics not using asthma medication.
One may envisage several biological mechanisms that could link gum bleeding with asthma. Airborne exposures are likely to be partly common, although filter functions of the nasal cavity reduce exposures to the lower airways. The mucosae of the oral cavity and the upper and the lower airways constitutes a continuum, which suggests a role for oral bacteria in respiratory health , i.e. by direct transport of oral bacteria or by transport of inflammatory substances. The present analysis shows that asthma was more strongly associated with gum bleeding among current smokers. Gum bleeding is less common in smokers due to vaso-constrictive effects on the gums. It is known that smoking increases the activity of the aggressive oral pathogen Porfyromonas Gingivalis [38–40], and that smokers have characteristic microbial communities that may contribute to respiratory tract complications . Further, smoking destroys the cilia in on the lower airways. Activated aggressive oral pathogens and enhanced deposition along damaged airways mucosa could explain the observed effect modification by smoking, and we hypothesise that oral pathogens and transport from oral to airways mucosae contribute to the association of gum bleeding with respiratory pathology.
Systemic factors are likely to influence the oral mucosa as well as the mucosa of the lower airways. It has been suggested that both periodontal and respiratory diseases are related to common immunological components that affect epithelia in both periodontal and respiratory tissues. One such common factor is matrix metalloproteases , responsible for the breakdown of collagen, and found at elevated levels during the periodontal breakdown process as well as related to bronchial remodelling in individuals with severe asthma[43, 44]. In addition, gingival IgE concentrations have been found to be elevated both among patients with asthma and among patients with periodontitis . Individual variations in defence mechanisms in the oral cavity and the airways might have similarities, and this could possibly contribute to the association of asthma with gum bleeding.
One might expect that systemic inflammation would be important for the relationship between periodontal health and obstructive airways disease . In the present analysis this was not found, as adjustments for a range of cardio-metabolic factors characterised by systemic inflammation did not attenuate the association of asthma with gum bleeding, and the association was present in all sub-groups when stratifying for BMI. One may therefore suspect that other mechanisms than common systemic inflammation are important for the association between gum bleeding and obstructive airways disease.
GERD causes acidic exposure to both the oral cavity and the airways, and it is well known that GERD is a cause of gingivitis and gum bleeding  as well as of asthma and respiratory symptoms . Adjustment for GERD attenuated slightly the association of gum bleeding with asthma. The findings suggest that factors acting on the mucosae of the oral cavity and the airways may be of importance for the link between oral and airways health.
Self-reported gum bleeding may be subject to reporting bias. We measured CPI index in a subsample of participants in one centre (Bergen, Norway), and found that self-reported gum bleeding was strongly related to measured periodontal pathology. Thus, the report of gum bleeding appeared to reflect periodontal pathology reasonably well. However, any errors in reporting of gum bleeding are unlikely to be differential according to asthma status, thus, such error is likely to have caused non-differential bias and attenuated true associations.
Smokers experience generally less gum bleeding than non-smokers. Rest confounding by smoking would thus be negative, and would have attenuated rather than increased observed associations between asthma symptoms and gum bleeding. Accordingly, adjustment for number of cigarettes smoked daily among current smokers increased very slightly the association of gum bleeding with asthma symptoms. We also found that the association between gum bleeding was particularly strong in current smokers.
The present analysis suggests an important relationship between oral health and asthma. The findings were consistent by various ways of analyses, consistent between centres with different prevalence of gum bleeding and asthma, and not related to effects of asthma medication. Interpreted in the light of previous literature, the findings suggest that aggressive oral pathogens as well as local factors of the mucosa of the oral cavity and airways may be important for the link between oral and airways health. Further insight into this might provide important opportunities for intervention that have been very little explored until now.
Conceived and designed the experiments: FGR LPB KF EL APS ANÅ CJ CS. Performed the experiments: FGR KF EL RJB BB BF TG RJ AJ EO ES VS TDS KT CJ CS. Analyzed the data: FGR LPB ØS CS. Wrote the paper: FGR LPB ANÅ CS.
- 1. Petersen PE, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontology 2000. 2012;60(1):15–39. pmid:22909104.
- 2. D'Aiuto F, Graziani F, Tete S, Gabriele M, Tonetti MS. Periodontitis: from local infection to systemic diseases. International journal of immunopathology and pharmacology. 2005;18(3 Suppl):1–11. pmid:16848982.
- 3. Greenstein G. The role of bleeding upon probing in the diagnosis of periodontal disease. A literature review. J Periodontol. 1984;55(12):684–8. pmid:6394735.
- 4. Armitage GC. Development of a classification system for periodontal diseases and conditions. Annals of periodontology / the American Academy of Periodontology. 1999;4(1):1–6. pmid:10863370.
- 5. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. pmid:25534621; PubMed Central PMCID: PMC4276050.
- 6. Lindenmeyer A, Bowyer V, Roscoe J, Dale J, Sutcliffe P. Oral health awareness and care preferences in patients with diabetes: a qualitative study. Family practice. 2013;30(1):113–8. pmid:22552313.
- 7. Uppoor AS, Lohi HS, Nayak D. Periodontitis and Alzheimer's disease: oral systemic link still on the rise? Gerodontology. 2013;30(3):239–42. pmid:22458804.
- 8. Sparks Stein P, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2012;8(3):196–203. pmid:22546352; PubMed Central PMCID: PMC3712346.
- 9. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125(20):2520–44. pmid:22514251.
- 10. Straka M, Trapezanlidis M, Dzupa P, Pijak R. Associations between marginal periodontitis and rheumatoid arthritis. Neuro Endocrinol Lett. 2012;33(1):16–20. pmid:22467106.
- 11. Deo V, Bhongade ML, Ansari S, Chavan RS. Periodontitis as a potential risk factor for chronic obstructive pulmonary disease: a retrospective study. Indian journal of dental research: official publication of Indian Society for Dental Research. 2009;20(4):466–70. pmid:20139573.
- 12. Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjortuft O, Olsen I. Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med. 2008;102(4):488–94. pmid:18191392.
- 13. Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO, et al. Periodontitis and airway obstruction. J Periodontol. 2005;76(11 Suppl):2161–7. Epub 2005/11/10. pmid:16277589.
- 14. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol. 2001;72(1):50–6. Epub 2001/02/24. pmid:11210073.
- 15. Si Y, Fan H, Song Y, Zhou X, Zhang J, Wang Z. Association between periodontitis and chronic obstructive pulmonary disease in a Chinese population. J Periodontol. 2012;83(10):1288–96. pmid:22248220.
- 16. Lintula T, Laitala V, Pesonen P, Sipila K, Laitala ML, Taanila A, et al. Self-reported oral health and associated factors in the North Finland 1966 birth cohort at the age of 31. BMC oral health. 2014;14:155. pmid:25516106; PubMed Central PMCID: PMC4274689.
- 17. Rath SK, Mukherjee M, Kaushik R, Sen S, Kumar M. Periodontal pathogens in atheromatous plaque. Indian journal of pathology & microbiology. 2014;57(2):259–64. pmid:24943760.
- 18. Ercan E, Eratalay K, Deren O, Gur D, Ozyuncu O, Altun B, et al. Evaluation of periodontal pathogens in amniotic fluid and the role of periodontal disease in pre-term birth and low birth weight. Acta odontologica Scandinavica. 2013;71(3–4):553–9. pmid:23638858.
- 19. Swati P, Thomas B, Vahab SA, Kapaettu S, Kushtagi P. Simultaneous detection of periodontal pathogens in subgingival plaque and placenta of women with hypertension in pregnancy. Arch Gynecol Obstet. 2012;285(3):613–9. pmid:21830010.
- 20. Katz J, Chegini N, Shiverick KT, Lamont RJ. Localization of P. gingivalis in preterm delivery placenta. Journal of dental research. 2009;88(6):575–8. pmid:19587165; PubMed Central PMCID: PMC3144059.
- 21. Madianos PN, Bobetsis YA, Offenbacher S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Periodontol. 2013;84(4 Suppl):S170–80. pmid:23631577.
- 22. Moutsopoulos NM, Madianos PN. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann N Y Acad Sci. 2006;1088:251–64. pmid:17192571.
- 23. Dasanayake AP. C-reactive protein levels are elevated in patients with periodontitis and their CRP levels may go down after periodontal therapy. The journal of evidence-based dental practice. 2009;9(1):21–2. pmid:19269611.
- 24. Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragao Farias NS, et al. Chronic periodontitis and C-reactive protein levels. J Periodontol. 2011;82(7):969–78. pmid:21189085.
- 25. Zhou X, Han J, Liu Z, Song Y, Wang Z, Sun Z. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial. J Clin Periodontol. 2014;41(6):564–72. pmid:24593836.
- 26. Santos NC, Jamelli S, Costa L, Baracho Filho C, Medeiros D, Rizzo JA, et al. Assessing caries, dental plaque and salivary flow in asthmatic adolescents using inhaled corticosteroids. Allergol Immunopathol (Madr). 2012;40(4):220–4. pmid:21862197.
- 27. Stensson M, Wendt LK, Koch G, Oldaeus G, Lingstrom P, Birkhed D. Caries prevalence, caries-related factors and plaque pH in adolescents with long-term asthma. Caries research. 2010;44(6):540–6. pmid:21051892.
- 28. Stensson M, Wendt LK, Koch G, Oldaeus G, Ramberg P, Birkhed D. Oral health in young adults with long-term, controlled asthma. Acta odontologica Scandinavica. 2011;69(3):158–64. pmid:21231815.
- 29. Laurikainen K, Kuusisto P. Comparison of the oral health status and salivary flow rate of asthmatic patients with those of nonasthmatic adults—results of a pilot study. Allergy. 1998;53(3):316–9. pmid:9542614.
- 30. Vargas MH, Macedo-Sanchez F, Solis-Torres C, Rubio-Monteverde H, Furuya ME. Oral hygiene and dental status as factors related to asthma in high school and college students. J Asthma. 2014:1–6. pmid:25329678.
- 31. Ersin NK, Gulen F, Eronat N, Cogulu D, Demir E, Tanac R, et al. Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition. Pediatrics international: official journal of the Japan Pediatric Society. 2006;48(6):549–54. pmid:17168972.
- 32. Johannessen A, Verlato G, Benediktsdottir B, Forsberg B, Franklin K, Gislason T, et al. Longterm follow-up in European respiratory health studies—patterns and implications. BMC pulmonary medicine. 2014;14:63. pmid:24739530; PubMed Central PMCID: PMC4021078.
- 33. Pekkanen J, Sunyer J, Anto JM, Burney P. Operational definitions of asthma in studies on its aetiology. Eur Respir J. 2005;26(1):28–35. pmid:15994386.
- 34. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). International dental journal. 1982;32(3):281–91. pmid:6958657.
- 35. WHO, Petersen PK, Baez RJ. Oral health surveys: basic methods. 5th ed: World Health Organization; 2013.
- 36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. pmid:3802833.
- 37. Gomes-Filho IS, Passos JS, Seixas da Cruz S. Respiratory disease and the role of oral bacteria. J Oral Microbiol. 2010;2. pmid:21523216; PubMed Central PMCID: PMC3084574.
- 38. Zeller I, Hutcherson JA, Lamont RJ, Demuth DR, Gumus P, Nizam N, et al. Altered antigenic profiling and infectivity of Porphyromonas gingivalis in smokers and non-smokers with periodontitis. J Periodontol. 2014;85(6):837–44. pmid:24147843.
- 39. Bagaitkar J, Daep CA, Patel CK, Renaud DE, Demuth DR, Scott DA. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation. PLoS One. 2011;6(11):e27386. pmid:22110637; PubMed Central PMCID: PMC3215692.
- 40. Bagaitkar J, Demuth DR, Daep CA, Renaud DE, Pierce DL, Scott DA. Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity. PLoS One. 2010;5(5):e9323. pmid:20454607; PubMed Central PMCID: PMC2864253.
- 41. Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, Sinha R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One. 2010;5(12):e15216. pmid:21188149; PubMed Central PMCID: PMC3004851.
- 42. Zhang L, Gang J, Zhigang C, Yali C, Baozhong S, Fangbiao Z, et al. Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. Wiener klinische Wochenschrift. 2014;126(17–18):515–23. pmid:25138548.
- 43. Costalonga M, Herzberg MC. The oral microbiome and the immunobiology of periodontal disease and caries. Immunology letters. 2014;162(2 Pt A):22–38. pmid:25447398.
- 44. Warburton D, Gauldie J, Bellusci S, Shi W. Lung development and susceptibility to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(8):668–72. Epub 2006/10/27. pmid:17065371.
- 45. Hyyppa T. Gingival IgE and histamine concentrations in patients with asthma and in patients with periodontitis. J Clin Periodontol. 1984;11(2):132–7. pmid:6583212.
- 46. Goodson JM, Groppo D, Halem S, Carpino E. Is obesity an oral bacterial disease? Journal of dental research. 2009;88(6):519–23. Epub 2009/07/10. pmid:19587155; PubMed Central PMCID: PMC2744897.
- 47. Song JY, Kim HH, Cho EJ, Kim TY. The relationship between gastroesophageal reflux disease and chronic periodontitis. Gut and liver. 2014;8(1):35–40. pmid:24516699; PubMed Central PMCID: PMC3916685.
- 48. Gunnbjornsdottir MI, Omenaas E, Gislason T, Norrman E, Olin AC, Jogi R, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J. 2004;24(1):116–21. pmid:15293613.